昂利康股价跌5.02%，建信基金旗下1只基金重仓，持有4.28万股浮亏损失11.94万元

Company Overview - Angli康's stock price dropped by 5.02% to 52.83 CNY per share, with a trading volume of 897 million CNY and a turnover rate of 8.70%, resulting in a total market capitalization of 10.657 billion CNY [1] - The company, Zhejiang Angli康 Pharmaceutical Co., Ltd., was established on December 30, 2001, and went public on October 23, 2018. Its main business involves the research, production, and sales of chemical raw materials and formulations [1] Revenue Composition - The revenue composition of Angli康 is as follows: raw materials account for 48.60%, formulations for 35.57%, specialty intermediates for 13.01%, other products for 1.61%, and pharmaceutical excipients for 1.21% [1] Fund Holdings - According to data, one fund under Jianxin Fund holds a significant position in Angli康. Jianxin Xingheng Optimal One-Year Holding Mixed A (014781) held 42,800 shares in the second quarter, representing 2.82% of the fund's net value, making it the fifth-largest holding [2] - The fund has a total scale of 43.6484 million CNY and has achieved a return of 48.06% this year, ranking 602 out of 8194 in its category. Over the past year, it has returned 59.06%, ranking 1726 out of 7962 [2] - The fund manager, Ma Muqing, has been in position for 3 years and 243 days, with a total asset scale of 1.342 billion CNY. The best return during his tenure is 73.49%, while the worst is 26.23% [2]